Garantie de satisfaction à 100% Disponible immédiatement après paiement En ligne et en PDF Tu n'es attaché à rien
logo-home
Summary Neurogenetics €7,99
Ajouter au panier

Resume

Summary Neurogenetics

1 vérifier
 62 vues  4 fois vendu

In this summary (based on my own notes and PPT) you can find all the chapters that are given in the Neurogenetics course. Color code: -Purple= 1. -Dark pink = 1.1. -Light pink = 1.1.1. -Green= 1.1.1.1 - Blue= 1.1.1.1.1 Important abbreviations: - N = neuron - B= brain - !!! = importa...

[Montrer plus]

Aperçu 3 sur 23  pages

  • 17 octobre 2023
  • 23
  • 2022/2023
  • Resume
Tous les documents sur ce sujet (18)

1  vérifier

review-writer-avatar

Par: arvamaria • 6 mois de cela

avatar-seller
evevlaemynck
NEUROLOGICAL DISORDERS TYPICAL THINGS IN
NEUROGENETICS: INTRODUCTION
= disease CNS & PNS, so: B, spinal cord, NEURLOGICAL DISORDERS
cranial nerves, peripheral nerves, nerve II. DEMENTIAS V. PAROXYSMAL DISORDERS > multiple disease subtypes
roots, ANS, neuromuscular junction & > multiple ≠ presentations disease within
muscles AD, frontotemporal dementia (FTD), = disorder occur unexpectedly in episodes family
→ eg. Alzheimer (AD), epilepsy, cerebro- dementia with Lewy bodies (DLB) & prion → epilepsy, migraine, episodic ataxias,... > challenging diagnosis
vascular diseases,... disease
> progressive disease + no cure
→ neuro-infections, traumatic VI. NEURODEVELOPMENTAL → makes patients motivated to
disorders & neurological disorders DISORDERS participate in research
bcs of malnutrition are ≠ -> not
neurogenetic
Autism spectrum disorder, sex chromosome FACTORS SUGGESTING
aneuploidies, Fragile X syndrome,... NEUROGENETIC DISORDERS
CLASSIFICATION > disease occurring in same family
> 200 neuro disorders -> can classify in
VII. NEUROCUTANEOUS
→ but familial disorders not always
many ways (age, cells, lobes,...) DISORDERS genetic & genetic disorders not
→ some diseases fit in multiple categories benign tumours in the B, but will lead to always familial !!!! -> think about
epilepsy environmental factors
are going to see 1 classification → neurofibromatosis type 1 (NF1) & > combination certain signs & symptoms
tuberous sclerosis complex (TSC) eg. facial acne + seizures = tuberous
I. MOVEMENT DISORDERS sclerosis
2 types: VIII. CEREBROVASCULAR → neurologist trained to
→ hypokinectic = slowness movement III. DISEASES OF WM DISEASES recognize symptoms
→ hyperkinetic = excessive involuntary 2 types: > chronic & progressive disease course
> dysmyelinating = primary abnormality of diseases in the blood vessels in the B > consanguinity = parents related
movements
myelin formation (so from birth) → cerebral autosomal-dominant arterio- > ↑ frequency in specific ethnic group
Wilson disease, Parkinson, Huntington, > demyelinating = secondary destruction pathy with subcortical infarcts & leuko-
cerebellar ataxias,... normal myelin encephalopathy (CADASIL) genetic, but doesn’t look like it?
→ was present, but is destroyed > reduced penetrance
= destruction cerebellum → MS!!!! = snowflake disease: loss of IX. MAJOR ADULT > de novo mutations
→ less control over movement, speech, loss of balance,... PSYCHIATRIC DISORDERS > sometimes parents die early -> doesn’t
balance & coordination → symptoms change over time look genetic
B cells are not dying, but it’s more a > non paternity (no info about true father)
→ ≠ types: Friederichs’s (most (worse/better) disorder in the functioning of the B
common), AOA2 (rare),... → addiction, obsessive compulsive
→ some genetic, others not (B IV. NEUROMUSCULAR
disorder & bipolar disorder
injury & alcohol) DISORDERS
→ snowflake disease: ≠ for everyone affects upper & lower motor N (UMN & LMN)
+ muscles
→ facioscapulohumeral muscular dystrophy,
amyotrophic lateral sclerosis (ALS), Duchenne
muscular dystrophy,...

, look at which chr. + region disease gene is CANDIDATE GENE APPROACH POLYGENIC RISK SCORE
located
→ makes use of LOD scores (>3 = prove only test 1 gene 2 step approach:
→ very biased method, bcs you have a a) get info on population level
of linkage)
biological reason to test gene + low b) generate polygenic risk score (PRS)
statistical burden of proof (p<0,05)
FROM MONOGENIC PROBLEMS WITH LA → but works sometimes = index derived by adding up #variants
DISORDERS TO COMPLEX > sporadic diseases x effect size
> unclear inheritance pattern HAPMAP PROJECT → gives info about risk of developing
DISEASES > it’s time consuming & costly disease: high/low = high/low risk
I. MONOGENIC: clear phenotype with = catalogue of genetic variants
> reduced penetrance: have disease gene, → based on combined effects
Mendelian inheritance but no/less symptoms → contains variants of 11 populations
→ PRS generated on population level
II. OLIGOGENIC: variable phenotype + > phenocopies = phenotype looks the same → allowed design of genome-wide panels
& applied individual level
often multiple genes involved as gene of interest, but they don’t of markers for association studies
→ ONLY FOR COMMON VARIANTS
III. POLYGENIC: complex traits, multi- have disease gene
factorial & phenotypic heterogeneity GENOME-WIDE → which variants include in PRS?
> significance based (p-value
messes up linkage analysis ASSOCIATION STUDIES cutoff)
neuro disorder can present in all these ways eg. Dopa-responsive dystonia family (GWAS) > PW based
with GCH1 deletion > derived from other disease
GENE DISCOVERY → study did linkage analysis: GCH1 scanning markers across ≠ individuals to
many reasons to do genetic research: to determine overlap: see if
was not a candidate region find genetic variations associated with a diseases have influence on
> provides definitive diagnosis → new locus: DYT14 on same chr. specific disease
> understanding biology disorder each other
→ but they kept studying GCH1 → used to identify risk genes for neuro
> provides potential biomarkers disorders BURDEN ANALYSIS
& saw an rare mutation (del)
> therapeutic targets
> can give genetic counseling to family → so bcs of the phenocopy first classical GWAS performed with
the right gene was Manhatten plot used!!!! genotype array’s with common variants
excluded for candidate →dotted line = significance threshold →then exome/genome sequencing to
LINKAGE ANALYSIS (LA) gene region (p< 5 x 10-8) study rare variants
based on genetic distance (cM) & → every dot = variant → problem: lack of statistical
variant/haplotype sharing POPULATION GENETICS → only dots above line are power
→ screen entire genome significant
homogenous populations = “large families”
→ look for shared regions between burden analysis came into play
→ easy to collect unrelated patients
healthy & ill family members → groups rare variants based on
→ big problem = population stratification
biological info (don’t get this)
do this with genetic markers (400-1000):
> SNPs if control & patients are ≠ bcs of
> repeat sequences = short tandem another reason then the disease, you
repeats (STR) will find ≠ not related to disease
> mini-satellites: repeats 5bases or more
> microsatellites: repeat di-, tri- or
tetra nucleotides
> multi-allelic genotypes: 5-12 repeats

, COMMON (>1 or >5%) VS FAMILIAL ALS GENES PRS SUGGEST GENETIC MUTATIONS IN CODING
RARE (<<1) GENETIC > SOD1 = first identified → 100 ≠ dominant
OVERLAP BETWEEN ALS & SEQUENCE
MUTATIONS mutations → 1 exception p.D90A -> SHIZOPHRENIA I. MISSENSE = 1 AA changed
recessive (mostly Scandinavian population) took PRS from schizophrenia GWAS: looked for → can/cannot affect P function
> rare mutations in common disorders -> large depending on conservative or
> ALS2: recessive → juvenile ALS variants that ↑ risk schizophrenia
effects non-conservative + function AA
> C9orf72 = repeat expansion inherited → overlapped schizophrenia PRS with ALS
→ identified via LA in families: eg. II. NONSENSE: 1 AA changed -> forms
dominant → saw ↑ ALS cases compared to controls
Huntington stop codon
> common mutations -> large effect in groups with high schizophrenia PRS
most common cause repeat expansion, but → premature termination or
→ identified via LA translation
20% mutations of familial genes also found in EXOME SEQUENCING STUDY
> common variant -> small effect III. SILENT: does not change AA, but
sporadic patients
→ identified via GWAS studies & can → there’s sporadic penetrance IN ALS IDENTIFIED TBK1 can still have phenotypic effect
be combined with PRS MUTATION IV. INSERTION/DELETION = number
→ + see oligogenic basis in ALS
gene burden association study: WES in of bases that is multiple of 3
MANOLIO PLOT V. FRAMESHIFT = insertion/deletion
= multiple genes that work together to sporadic ALS patients & controls
cause ALS → identified TBK1 mutation in 1% of of number of bases not multiple of 3
→ multiple genes contributing to disease patients = rare variant → usually introduces pre STOP
causes phenotypic variability + goes VI. SPLICE SITE: changes DNA seq.
together with reduced penetrance !!! role in autophagy & neuro-inflammation at boundary exon & intron

these 3 connected TYPES OF DISEASE-CAUSING keep in mind: genes can have multiple
with each other GENETIC VARIATION transcripts
→ each transcript affected in ≠ ways
mutation classification by effect on DNA
molecule: NONSENSE MEDIATED
true, but rare variants most frequent I. SUBSTITUTION
type of variation in human genome !!! II. DELETION (can be in or out of frame) DECAY
→ find with burden analysis III. INSERT (can be in or out of frame) during splicing exon junction complexes
MOST NEURO DISEASES ENVIRONMENT & ALS IV. INVERSION = 180° rotation made on an exon-exon border
V. RECIPROKAL TRANSLOCATION: parts of
= GENETICALLY excessive sport changes expression ALS- nonhomologous chr. change places removed during 1st transcription by
HETEROGENEOUS WITH associated genes VI. CHROMOSOMAL REARRANGEMENTS: affects ribosome
→ a lot of sport = risk ALS↑ many genes at one time → when pre STOP EJC not removed
MULTIPLE MODES OF
→ signal to destroy mRNA: no P &
INHERITANCE ALS RISK GENES IDENTIFIED most !!! is outcome mutation on DNA, RNA or P less mRNA
eg. amyotrophic lateral sclerosis (ALS) THROUGH GWAS → effect will depend on if variant affects → pre STOP before last exon escape
→ UMN & LMN affected coding or non coding regions of genome NMD (<55 nucleotides before
most recent ALS-GWAS: 30.000 patients
→ 10% familial & 90% sporadic complex)
& 125.000 controls
→ can have single genes that → found 15 ALS risk loci → get shorter P & normal mRNA
cause ALS or multiple genes

Les avantages d'acheter des résumés chez Stuvia:

Qualité garantie par les avis des clients

Qualité garantie par les avis des clients

Les clients de Stuvia ont évalués plus de 700 000 résumés. C'est comme ça que vous savez que vous achetez les meilleurs documents.

L’achat facile et rapide

L’achat facile et rapide

Vous pouvez payer rapidement avec iDeal, carte de crédit ou Stuvia-crédit pour les résumés. Il n'y a pas d'adhésion nécessaire.

Focus sur l’essentiel

Focus sur l’essentiel

Vos camarades écrivent eux-mêmes les notes d’étude, c’est pourquoi les documents sont toujours fiables et à jour. Cela garantit que vous arrivez rapidement au coeur du matériel.

Foire aux questions

Qu'est-ce que j'obtiens en achetant ce document ?

Vous obtenez un PDF, disponible immédiatement après votre achat. Le document acheté est accessible à tout moment, n'importe où et indéfiniment via votre profil.

Garantie de remboursement : comment ça marche ?

Notre garantie de satisfaction garantit que vous trouverez toujours un document d'étude qui vous convient. Vous remplissez un formulaire et notre équipe du service client s'occupe du reste.

Auprès de qui est-ce que j'achète ce résumé ?

Stuvia est une place de marché. Alors, vous n'achetez donc pas ce document chez nous, mais auprès du vendeur evevlaemynck. Stuvia facilite les paiements au vendeur.

Est-ce que j'aurai un abonnement?

Non, vous n'achetez ce résumé que pour €7,99. Vous n'êtes lié à rien après votre achat.

Peut-on faire confiance à Stuvia ?

4.6 étoiles sur Google & Trustpilot (+1000 avis)

56326 résumés ont été vendus ces 30 derniers jours

Fondée en 2010, la référence pour acheter des résumés depuis déjà 14 ans

Commencez à vendre!
€7,99  4x  vendu
  • (1)
Ajouter au panier
Ajouté